Feng Yan-Mei, Yang Yuan, Han Xiao-Li, Zhang Fan, Wan Dong, Guo Rui
Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, P.R.China.
Department of Cardiovascular Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, P.R.China.
PLoS One. 2017 Mar 22;12(3):e0174158. doi: 10.1371/journal.pone.0174158. eCollection 2017.
The optimal timing for initiating renal replacement therapy (RRT) in patients with acute kidney injury (AKI) remains controversial.
We conducted a meta-analysis with trial sequential analysis (TSA) of randomized controlled trials (RCTs) using PUBMED, Cochrane Library databases, and Web of Science (from January 1, 1985, to August 21, 2016). Adult patients with AKI who received RRT with different timing were included. The primary outcome was mortality. The secondary outcomes were intensive care unit (ICU) length of stay (LOS) and hospital LOS.
We included 9 RCTs with a total of 1636 participants. No differences between the early RRT group and the late RRT group were found with respect to mortality (38% vs 41.4%; relative risk, 0.93; 95% confidence interval [CI], 0.74-1.18). However, TSA showed that the cumulative Z-curve did not cross either the conventional boundary for benefit or the trial sequential monitoring boundary, indicating insufficient evidence. Similarity, there were no findings of benefits in terms of reduction in the ICU LOS (standard difference in the means, -0.32 days; 95% CI, -0.71 to 0.07 days) and hospital LOS (standard difference in the means, -1.11 days; 95% CI, -2.28 to 0.06 days). Meanwhile, the results of TSA did not confirm this conclusion.
Although conventional meta-analysis showed that early initiation of RRT in patients with AKI was not associated with decreased mortality, ICU LOS and hospital LOS, TSA indicated that the data were far too sparse to make any conclusions. Therefore, well-designed, large RCTs are needed.
急性肾损伤(AKI)患者开始肾脏替代治疗(RRT)的最佳时机仍存在争议。
我们使用PUBMED、Cochrane图书馆数据库和科学网(从1985年1月1日至2016年8月21日)对随机对照试验(RCT)进行了荟萃分析,并进行了试验序贯分析(TSA)。纳入接受不同时机RRT的成年AKI患者。主要结局是死亡率。次要结局是重症监护病房(ICU)住院时间(LOS)和医院住院时间。
我们纳入了9项RCT,共1636名参与者。在死亡率方面,早期RRT组和晚期RRT组之间未发现差异(38%对41.4%;相对风险,0.93;95%置信区间[CI],0.74 - 1.18)。然而,TSA显示累积Z曲线未越过传统的获益边界或试验序贯监测边界,表明证据不足。同样,在降低ICU住院时间(平均标准差,-0.32天;95%CI,-0.71至0.07天)和医院住院时间(平均标准差,-1.11天;95%CI,-2.28至0.06天)方面也未发现获益。同时,TSA结果也未证实这一结论。
尽管传统荟萃分析表明AKI患者早期开始RRT与死亡率、ICU住院时间和医院住院时间的降低无关,但TSA表明数据过于稀疏,无法得出任何结论。因此,需要设计良好的大型RCT。